PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC), to address significant unmet medical ne ...

Crohn’s disease (CD) is a chronic, progressive inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal (GI) tract—from the mouth to the anus. It most commonly affects the ...

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is often perceived as a condition ...

In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new ...

Terminal ileum resection is associated with increased risk for colorectal cancer among individuals with Crohn disease.

Fatigue and exhaustion are hallmarks of Crohn's disease. Try these tips for more energy and better health overall.

In a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of Crohn's disease. High potato consumption, meanwhile, was tied to an ...

Cartabuke: The biggest challenges in the treatment of Crohn’s disease include managing refractory disease, preventing and treating complications, and addressing the high cost of biologic therapies.

Cedars-Sinai investigators have developed an investigational therapy that brought a significant number of patients with moderate to severe Crohn's disease into remission, according to a new study ...

For moderate to severe Crohn's disease, the combination of infliximab plus azathioprine appears to produce higher rates of clinical remission than either agent alone.

Watch the Demo Launch Trailer for Devil's Terminal, a punk-themed coming-of-age RPG developed by Drama. Players will explore the trials and tribulations of being a troubled teen, interfacing with ...